Fourth hospital of Shijiazhuang city Trials

Fourth hospital of Shijiazhuang city	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Gao, Ying

XMAS-2, NCT04150835: Xingnaojing for Mild-to-severe Acute Ischemic Stroke

Recruiting

1200

RoW

Xingnaojing injection, Xingnaojing placebo injection, Standard care

Dongzhimen Hospital, Beijing, Peking University Third Hospital, Beijing Shuyi Hospital, The Airport Hospital of Shunyi District Beijing, Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine, The NO.4 People's Hospital of Hengshui, The Second Hospital of Hebei Medical University, The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine, The Affiliated Hospital of Shaanxi University of Chinese Medicine, Tianshui Hospital of Traditional Chinese Medicine, The Affiliated Hospital of Changzhi Academy of TCM, Zibo Hospital of Traditional Chinese Medicine, Yantai Yuhuangding Hospital, Shandong University of Traditional Chinese Medicine, Zhejiang Provincial Hospital of TCM, Zhejiang Provincial Tongde Hospital, Second Affiliated Hospital of Wenzhou Medical University, People's Hospital of Quzhou, Longhua Hospital, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Taizhou Hospital of Traditional Chinese Medicine, The First Affiliated Hospital of Guizhou University of TCM, Guangzhou Hospital of Traditional Chinese Medicine, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Liling Hospital of Traditional Chinese Medicine, Hunan Academy of Traditional Chinese Medicine Affiliated Hospital, Hubei Hospital of Traditional Chinese Medicine, The First Hospital of Jilin University, Anshan Central Hospital, The Affiliated Hospital of Liaoning University of TCM, The First Hospital of Qiqihar City, Haikou People's Hospital, The Second People's Hospital of Anhui Province, The Third Affiliated Hospital of Shenzhen University, The third people's Hospital of Hubei Province, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, The Third Hospital of Xi'an City

Acute Ischemic Stroke, Stroke, Acute, Stroke, Ischemic

12/21

NCT04415164: Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke

Recruiting

480

RoW

Xueshuantong lyophilized powder, Zhusheyong Xueshuantong (donggan), WS-10460(ZD-0460)-2002-2011Z, Placebo, Guidelines-based standard care

Dongzhimen Hospital, Beijing, Tianjin University of Traditional Chinese Medicine

Acute Ischemic Stroke

10/22

05/23

LIGHT, NCT06653907: Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody

Not yet recruiting

400

RoW

Levothyroxine Sodium (LT4) Tablets, Placebo

Yang ZHANG, National Research Institute for Family Planning, China, Fourth Hospital of Shijiazhuang City

Thyroid Abnormalities, Pregnant Woman, Pregnancy Outcomes

12/26

10/27

NCT04875169: Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Completed

336

Canada, RoW

Core Treatment Active Experimental: SHR0302 Dose#1, Core Treatment Active Experimental: SHR0302 Dose#2, Core Treatment Placebo Comparator: Placebo, Extension Treatment Active Experimental: SHR0302 Dose#1, Extension Treatment Active Experimental: SHR0302 Dose#2

Reistone Biopharma Company Limited

Atopic Dermatitis

08/22

05/23

NCT06280716: A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis

Recruiting

430

RoW

Placebo, Lebrikizumab, LY3650150, Topical Corticosteroid

Eli Lilly and Company

Atopic Dermatitis

12/25

11/26

NCT06775860: ICP-332 in Subjects with Moderate to Severe Atopic Dermatitis

Recruiting

552

RoW

ICP-332 Tablets, ICP-332 Placebo Tablets

Beijing InnoCare Pharma Tech Co., Ltd.

Atopic Dermatitis

11/26

12/26

BOSS, NCT04408261: BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome

Recruiting

432

RoW

Buqitongluo Granule, Buqitongluo Granule Placebo, Standard care

Dongzhimen Hospital, Beijing, The Affiliated Hospital of Changchun University of Chinese Medicine, The Affiliated Hospital of Shandong University of Chinese Medicine, The Affiliated Hospital of Chengdu University of Chinese Medicine, The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, The Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine, Hunan Academy of Traditional Chinese Medicine Affiliated Hospital, The First Clinical Hospital of Jilin Academy of Traditional Chinese Medicine, Shaanxi Buchang Pharmaceuticals Co., Ltd., Beijing Chuanglikechuang Medical Technology Development Co., Ltd., Shanghai Youningwei Biotechnology Co., Ltd., Wuhan Zhizhi Medical Technology Co., Ltd., Wuhan Third Hospital-Tongren Hospital of Wuhan University, Rizhao Hospital of Traditional Chinese Medicine, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Jiangbin Hospital of Guangxi Zhuang Autonomous Region

Stroke, Ischemic, Coronary Artery Disease, Angina Pectoris, Stable, Diabetic Peripheral Neuropathy

12/22

NCT06490263: the Safety, Tolerability and Pharmacokinetics of Mulberry Twig Alkaloids in Human

Recruiting

RoW

Experimental: Mulberry Twig Alkaloids Tablets 126 mg single dose in healthy subjects, WH006, Mulberry Twig Alkaloids Tablets with single dose in healthy subjects, Mulberry Twig Alkaloids Tablets with multiple dose in healthy subjects, Mulberry Twig Alkaloids Tablets with multiple dose in overweight or obese subjects

Beijing Wehand-Bio Pharmaceutical Co., Ltd, Peking University First Hospital

Overweight and Obesity, Healthy

10/24

12/24

NCT04813445: Analysing the Effects of Xingnaojing for Mild-to-severe Acute Ischemic Stroke

Recruiting

N/A

RoW

Xingnaojing injection

Dongzhimen Hospital, Beijing, Affiliated Hospital of Nantong University, Nanjing Brian Hospital, Affiliated Hospital of Chengde Medical University

Acute Stroke, Ischemic Stroke

06/22

09/22

NCT06470477: Molecular Characteristics of Phlegm-heat Syndrome in Ischemic Stroke

Not yet recruiting

N/A

RoW

Guideline-based treatment, Routine care

Dongzhimen Hospital, Beijing

Ischemic Stroke, Acute

12/24

PIONEER, NCT06861426: Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke

Not yet recruiting

N/A

4460

RoW

Ginkgo Diterpene Lactone Meglumine, Ginkgo Diterpene Lactone Meglumine Injection, Diterpene Ginkgolides Meglumine Injection

Ying Gao

Acute Ischemic Stroke

09/25

12/25

TREASURE, NCT06049498: Trial of Mongolian Medicine ZhenBao Pills for Upper-limb Dysfunction After Stroke

Not yet recruiting

N/A

216

RoW

Mongolian Medicine ZhenBao Pills, Mongolian Medicine ZhenBao Pills Placebo

Dongzhimen Hospital, Beijing

Ischemic Stroke

10/25

12/25

CASES-TCM, NCT04921397: China Stroke Registry for Patients With Traditional Chinese Medicine

Not yet recruiting

N/A

20000

RoW

Dongzhimen Hospital, Beijing

Ischemic Stroke, Intracerebral Hemorrhage

12/24

06/25

CARE-TCM, NCT04885374: China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine

Recruiting

N/A

2000

RoW

Dongzhimen Hospital, Beijing

Amyotrophic Lateral Sclerosis

05/27

03/28

zhang, guohua

LIGHT, NCT06653907: Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody

Not yet recruiting

400

RoW

Levothyroxine Sodium (LT4) Tablets, Placebo

Yang ZHANG, National Research Institute for Family Planning, China, Fourth Hospital of Shijiazhuang City

Thyroid Abnormalities, Pregnant Woman, Pregnancy Outcomes

12/26

10/27

NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting

8250

RoW

Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy

Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.

Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases

04/25

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Gao, Ying

XMAS-2, NCT04150835: Xingnaojing for Mild-to-severe Acute Ischemic Stroke

Recruiting

1200

RoW

Xingnaojing injection, Xingnaojing placebo injection, Standard care

Acute Ischemic Stroke, Stroke, Acute, Stroke, Ischemic

12/21

NCT04415164: Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke

Recruiting

480

RoW

Xueshuantong lyophilized powder, Zhusheyong Xueshuantong (donggan), WS-10460(ZD-0460)-2002-2011Z, Placebo, Guidelines-based standard care

Dongzhimen Hospital, Beijing, Tianjin University of Traditional Chinese Medicine

Acute Ischemic Stroke

10/22

05/23

LIGHT, NCT06653907: Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody

Not yet recruiting

400

RoW

Levothyroxine Sodium (LT4) Tablets, Placebo

Yang ZHANG, National Research Institute for Family Planning, China, Fourth Hospital of Shijiazhuang City

Thyroid Abnormalities, Pregnant Woman, Pregnancy Outcomes

12/26

10/27

NCT04875169: Evaluate Efficacy and Safety of Oral SHR0302 in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

Completed

336

Canada, RoW

Reistone Biopharma Company Limited

Atopic Dermatitis

08/22

05/23

NCT06280716: A Study of Lebrikizumab (LY3650150) With/Without Topical Corticosteroid Treatment in Participants With Moderate-to-Severe Atopic Dermatitis

Recruiting

430

RoW

Placebo, Lebrikizumab, LY3650150, Topical Corticosteroid

Eli Lilly and Company

Atopic Dermatitis

12/25

11/26

NCT06775860: ICP-332 in Subjects with Moderate to Severe Atopic Dermatitis

Recruiting

552

RoW

ICP-332 Tablets, ICP-332 Placebo Tablets

Beijing InnoCare Pharma Tech Co., Ltd.

Atopic Dermatitis

11/26

12/26

BOSS, NCT04408261: BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome

Recruiting

432

RoW

Buqitongluo Granule, Buqitongluo Granule Placebo, Standard care

Stroke, Ischemic, Coronary Artery Disease, Angina Pectoris, Stable, Diabetic Peripheral Neuropathy

12/22

NCT06490263: the Safety, Tolerability and Pharmacokinetics of Mulberry Twig Alkaloids in Human

Recruiting

RoW

Beijing Wehand-Bio Pharmaceutical Co., Ltd, Peking University First Hospital

Overweight and Obesity, Healthy

10/24

12/24

NCT04813445: Analysing the Effects of Xingnaojing for Mild-to-severe Acute Ischemic Stroke

Recruiting

N/A

RoW

Xingnaojing injection

Dongzhimen Hospital, Beijing, Affiliated Hospital of Nantong University, Nanjing Brian Hospital, Affiliated Hospital of Chengde Medical University

Acute Stroke, Ischemic Stroke

06/22

09/22

NCT06470477: Molecular Characteristics of Phlegm-heat Syndrome in Ischemic Stroke

Not yet recruiting

N/A

RoW

Guideline-based treatment, Routine care

Dongzhimen Hospital, Beijing

Ischemic Stroke, Acute

12/24

PIONEER, NCT06861426: Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke

Not yet recruiting

N/A

4460

RoW

Ginkgo Diterpene Lactone Meglumine, Ginkgo Diterpene Lactone Meglumine Injection, Diterpene Ginkgolides Meglumine Injection

Ying Gao

Acute Ischemic Stroke

09/25

12/25

TREASURE, NCT06049498: Trial of Mongolian Medicine ZhenBao Pills for Upper-limb Dysfunction After Stroke

Not yet recruiting

N/A

216

RoW

Mongolian Medicine ZhenBao Pills, Mongolian Medicine ZhenBao Pills Placebo

Dongzhimen Hospital, Beijing

Ischemic Stroke

10/25

12/25

CASES-TCM, NCT04921397: China Stroke Registry for Patients With Traditional Chinese Medicine

Not yet recruiting

N/A

20000

RoW

Dongzhimen Hospital, Beijing

Ischemic Stroke, Intracerebral Hemorrhage

12/24

06/25

CARE-TCM, NCT04885374: China Amyotrophic Lateral Sclerosis Registry of Patients With Traditional Chinese Medicine

Recruiting

N/A

2000

RoW

Dongzhimen Hospital, Beijing

Amyotrophic Lateral Sclerosis

05/27

03/28

zhang, guohua

LIGHT, NCT06653907: Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody

Not yet recruiting

400

RoW

Levothyroxine Sodium (LT4) Tablets, Placebo

Yang ZHANG, National Research Institute for Family Planning, China, Fourth Hospital of Shijiazhuang City

Thyroid Abnormalities, Pregnant Woman, Pregnancy Outcomes

12/26

10/27

NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)

Active, not recruiting

8250

RoW

Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy

Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd.

04/25



	Diseases Companies Products Productz Mechanisms of Action Sites